Diagenode’s CRISPR/Cas9 polyclonal antibody has been raised against the N-terminus of the Cas9 nuclease, extensively validated and optimized for excellent specificity and high yields in chromatin IP.
Contact us |
Conditions of sales |
Conditions of purchase |
Create a new account -
I forgot my password
To ensure you see the information most relevant to you, please select your country.
Please note that your browser will need to be configured to accept cookies.